Betaxolol hydrochloride for the treatment of anxiety disorders

Details Betaxolol hydrochloride for the treatment of anxiety disorders Betaxolol hydrochloride for the treatment of anxiety disorders

1996-04-02

1998-08-25

Jarvis, William R. A.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 31135

Patent

active

057983933

ABSTRACT:
The compound betaxolol has the chemical formula: .
It is administered, preferably orally, once per day in 4-12 mg. tablets for the treatment of symptoms of anxiety disorder in human patients. Such symptoms include those present in Generalized Anxiety Disorder (GAD), which include somatic symptoms such as panic, palpitations and pounding heart.

REFERENCES:
patent: 5525347 (1996-06-01), Kellner et al.
Le Van et al, Therapie, vol. 43, No. 6, pp. 451-456, 1988.
Thomas, C. L., Ed., Taber's Cyclopedia Medical Dictionary, 17th Edition, pp. 129 and 129, 1993.
Turner, Derwent Drug File Abstracts, Abstract No. 89-09926, 1989.

Affiliated with

Also associated with

Rating

Betaxolol hydrochloride for the treatment of anxiety disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Betaxolol hydrochloride for the treatment of anxiety disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Betaxolol hydrochloride for the treatment of anxiety disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-36778